Skip to main content Accessibility help
×
Home

The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans

  • Emma L. Wightman (a1), Crystal F. Haskell-Ramsay (a1), Jonathon L. Reay (a2), Gary Williamson (a3), Tristan Dew (a3) (a4), Wei Zhang (a3) and David O. Kennedy (a1)...

Abstract

Single doses of resveratrol have previously been shown to increase cerebral blood flow (CBF) with no clear effect on cognitive function or mood in healthy adults. Chronic resveratrol consumption may increase the poor bioavailability of resveratrol or otherwise potentiate its psychological effects. In this randomised, double-blind, placebo-controlled, parallel-groups study, a total of sixty adults aged between 18 and 30 years received either placebo or resveratrol for 28 d. On the 1st and 28th day of treatment, the performance of cognitively demanding tasks (serial subtractions, rapid visual information processing and 3-Back) (n 41 complete data sets) was assessed, alongside blood pressure (n 26) and acute (near-IR spectroscopy (NIRS)) and chronic (transcranial Doppler) measures of CBF (n 46). Subjective mood, sleep quality and health questionnaires were completed at weekly intervals (n 53/54). The results showed that the cognitive effects of resveratrol on day 1 were restricted to more accurate but slower serial subtraction task performance. The only cognitive finding on day 28 was a beneficial effect of resveratrol on the accuracy of the 3-Back task before treatment consumption. Subjective ratings of ‘fatigue’ were significantly lower across the entire 28 d in the resveratrol condition. Resveratrol also resulted in modulation of CBF parameters on day 1, as assessed by NIRS, and significantly increased diastolic blood pressure on day 28. Levels of resveratrol metabolites were significantly higher both before and after the day’s treatment on day 28, in comparison with day 1. These results confirm the acute CBF effects of resveratrol and the lack of interpretable cognitive effects.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans
      Available formats
      ×

Copyright

Corresponding author

* Corresponding author: E. L. Wightman, email emma.l.wightman@northumbria.ac.uk

References

Hide All
1. Fremont, L (2000) Biological effects of resveratrol. Life Sci 66, 663673.
2. Kennedy, DO, Wightman, EL, Reay, JL, et al. (2010) Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 91, 15901597.
3. Gresele, P, Pignatelli, P, Guglielmini, G, et al. (2008) Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 138, 16021608.
4. Rivera, L, Morón, R, Zarzuelo, A, et al. (2009) Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77, 10531063.
5. Rush, JWE, Quadrilatero, J, Levy, AS, et al. (2007) Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Ex Biol Med (Maywood) 232, 814822.
6. Wong, R, Howe, P, Buckley, J, et al. (2011) Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis 21, 851856.
7. Moss, MC, Scholey, AB & Wesnes, K (1998) Oxygen administration selectively enhances cognitive performance in healthy young adults: a placebo-controlled double-blind crossover study. Psychopharmacology (Berl) 138, 2733.
8. Scholey, A, Harper, S & Kennedy, D (2001) Cognitive demand and blood glucose. Physiol Behav 73, 585592.
9. Walle, T, Hsieh, F, DeLegge, MH, et al. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 13771382.
10. Boocock, DJ, Faust, GES, Patel, KR, et al. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev 16, 12461252.
11. Kuhnle, G, Spencer, JP, Chowrimootoo, G, et al. (2000) Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem Biophys Res Commun 272, 212217.
12. Wang, L, Heredia, A, Song, H, et al. (2004) Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J Pharma Sci 93, 24482457.
13. Marier, JF, Vachon, P, Gritsas, A, et al. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302, 369373.
14. Gescher, AJ & Steward, WP (2003) Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12, 953957.
15. Ide, K, Horn, A & Secher, NH (1999) Cerebral metabolic response to submaximal exercise. J Appl Physiol 87, 16041608.
16. Jia, Z, Zhu, H, Misra, BR, et al. (2008) EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol. Mol Cell Biochem 313, 187194.
17. Donnelly, LE, Newton, R, Kennedy, GE, et al. (2004) Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287, 774783.
18. Xu, Y, Wang, Z, You, W, et al. (2010) Antidepressant-like effect of trans-resveratrol: involvement of serotonin and noradrenaline system. Eur Neuropsychopharmacology 20, 405413.
19. Liu, C, Li, S, Liu, T, et al. (2007) Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism. Nature 447, 477481.
20. Markus, HS (2000) Transcranial Doppler ultrasound. Br Med Bull 56, 378388.
21. Nicoletto, HA & Burkman, MH (2009) Transcranial Doppler series part II: performing a transcranial Doppler. Am J Electroneurodiagnostic Technol 49, 1427.
22. Adams, R, McKie, V, Carl, E, et al. (1997) Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 42, 699704.
23. Vicenzini, E, Ricciardi, MC, Altieri, M, et al. (2007) Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study. Eur Neurol 58, 8489.
24. Harders, A, Laborde, G, Droste, D, et al. (1989) Brain activity and blood flow velocity changes: a transcranial Doppler study. Int J Neurosci 47, 91102.
25. Jones, HE, Herning, RI, Cadet, JL, et al. (2000) Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology (Berl) 147, 371377.
26. Herning, RI, King, DE, Better, WE, et al. (1999) Neurovascular deficits in cocaine abusers. Neuropsychopharmacology 21, 110118.
27. Kazui, H, Kitagaki, H & Mori, E (2000) Cortical activation during retrieval of arithmetical facts and actual calculation: a functional magnetic resonance imaging study. Psychiatry Clin Neurosci 54, 479485.
28. Coull, J, Frith, C, Frackowiak, RSJ, et al. (1996) A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory. Neuropsychologia 34, 10851095.
29. Jansma, JM, Ramsey, NF, Coppola, R, et al. (2000) Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage 12, 688697.
30. Goldberg, D (1978) Manual of the General Health Questionnaire. Windsor: NFER Publishing.
31. McNair, DM, Lorr, M & Droppleman, LF (1971) Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
32. Buysse, DJ, Reynolds, CF, Monk, TH, et al. (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28, 193213.
33. Wightman, E, Reay, J, Haskell, C, et al. (2014) Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in humans: a randomised, double-blind, placebo-controlled, crossover investigation. Br J Nutr 112, 203213.
34. Reay, JL, Scholey, AB & Kennedy, DO (2010) Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Hum Psychopharmacol 25, 462471.
35. Keppel, G (1991) Design and Analysis. Englewood Cliffs, NJ: Prentice Hall.
36. Lagouge, M, Argmann, C, Gerhart-Hines, Z, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha. Cell 127, 11091122.
37. Wong, R, Berry, N, Coates, A, et al. (2012) Sustained improvement of vasodilator function by resveratrol in obese adults. J Hypertens 30, e70.
38. Alvarez, E, Campos, M, Justiniano, H, et al. (2006) Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta. Br Pharmacol 147, 269280.
39. Stewart, LK, Soileau, JL, Ribnicky, D, et al. (2008) Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 57, S39S46.
40. Davis, JM, Murphy, EA, Carmichael, MD, et al. (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiolo 296, R1071R1077.
41. MacRae, HS & Mefferd, KM (2006) Dietary antioxidant supplementation combined with quercetin improves cycling time trial performance. Int J Sport Nutr Exerc Metab 16, 405-419.
42. Chen, CK & PaceAsciak, CR (1996) Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta. Gen Pharmacol 27, 363366.

Keywords

Type Description Title
WORD
Supplementary materials

Wightman supplementary material
Tables 1-4

 Word (38 KB)
38 KB

The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans

  • Emma L. Wightman (a1), Crystal F. Haskell-Ramsay (a1), Jonathon L. Reay (a2), Gary Williamson (a3), Tristan Dew (a3) (a4), Wei Zhang (a3) and David O. Kennedy (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed